TY  - JOUR
AU  - Apter, Jeffrey T.
AU  - White, Kaylee M.
PY  - 2020
DA  - 2020/04/29
TI  - New Horizons in Alzheimer Research from Amyloid and Beyond
JO  - OBM Geriatrics
SP  - 116
VL  - 04
IS  - 02
AB  - The Amyloid and Tau Hypothesis of Alzheimer’s disease once thought to be the key have shown marginal results but are bolstered by the recent revival of the Aducanumab study and some positive data on some anti-Tau drugs. It still behoves us to look at other mechanisms which include whole blood transfusions, an Epigenetic approach, a-derivative of a Parkinson's drug a low dose of an anti-epileptic drug, an antibiotic against P Gingivitis and many new approaches not directly involving Amyloid and Tau. Other newer approaches were also presented at CTAD 2019.
SN  - 2638-1311
UR  - https://doi.org/10.21926/obm.geriatr.2002116
DO  - 10.21926/obm.geriatr.2002116
ID  - Apter2020
ER  -